NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Panacea Biotec Limited (NSE: PANACEABIO)

 
PANACEABIO Technical Analysis
2
As on 25th Jan 2022 PANACEABIO Share Price closed @ 209.55 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 276.14 & Buy for SHORT-TERM with Stoploss of 199.35 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

PANACEABIO Share Price

Open 207.10 Change Price %
High 211.00 1 Day -0.80 -0.38
Low 203.15 1 Week 20.80 11.02
Close 209.55 1 Month 18.35 9.60
Volume 113938 1 Year 12.35 6.26
52 Week High 449.00 | 52 Week Low 165.30
 
NSE INDIA Most Active Stocks
IDEA 11.30 3.20%
VISESHINFO 1.55 3.33%
JPPOWER 9.05 2.84%
SUZLON 11.00 -0.90%
ZOMATO 100.45 9.96%
YESBANK 13.60 1.12%
BANKBARODA 98.50 6.37%
PNB 39.40 3.68%
ALOKINDS 29.70 2.77%
INVENTURE 5.45 -4.39%
 
NSE INDIA Top Gainers Stocks
SALONA 327.00 20.00%
SHARDACROP 525.35 20.00%
AMBICAAGAR 34.05 18.85%
PRESSMN 48.65 16.67%
CORALFINAC 49.85 14.60%
TRITURBINE 214.30 14.42%
OMAXE 93.10 13.95%
ARMANFIN 792.95 13.76%
ORBTEXP 100.00 13.44%
BIL 304.25 12.31%
 
NSE INDIA Top Losers Stocks
LUXIND 2813.70 -20.00%
MOKSH 31.50 -16.89%
INDIAMART 5005.00 -14.27%
APLAPOLLO 861.90 -8.20%
NORBTEAEXP 9.05 -7.65%
IGPL 651.45 -6.29%
DEEPAKNTR 2216.00 -6.25%
CARTRADE 721.25 -6.12%
HATSUN 1034.35 -5.88%
NAZARA 2267.20 -5.00%
 
 
PANACEABIO
Daily Charts
PANACEABIO
Intraday Charts
Whats New @
Bazaartrend
PANACEABIO
Free Analysis
 
PANACEABIO Important Levels Intraday
RESISTANCE224.68
RESISTANCE219.83
RESISTANCE216.83
RESISTANCE213.83
SUPPORT205.27
SUPPORT202.27
SUPPORT199.27
SUPPORT194.42
 
PANACEABIO Target for Month January
4th UP TARGET298.95
3rd UP TARGET266.78
2nd UP TARGET246.9
1st UP TARGET227.02
1st DOWN TARGET170.28
2nd DOWN TARGET150.4
3rd DOWN TARGET130.52
4th DOWN TARGET98.35
 
PANACEABIO Weekly Target
4th UP TARGET258.85
3rd UP TARGET243.58
2nd UP TARGET234.15
1st UP TARGET224.71
1st DOWN TARGET197.79
2nd DOWN TARGET188.35
3rd DOWN TARGET178.92
4th DOWN TARGET163.65
 
PANACEABIO Target for Year 2022
4th UP TARGET745.34
3rd UP TARGET570.01
2nd UP TARGET461.64
1st UP TARGET353.27
1st DOWN TARGET44.03
2nd DOWN TARGET-64.34
3rd DOWN TARGET-172.71
4th DOWN TARGET-348.04
 
 
PANACEABIO Synopsis Technicals View
50 Day EMA Close is Above EMA 50 (Short Term)
Bullish
100 Day EMA Close is Above EMA 100 (Mid Term) Bullish
200 Day EMA Close is Above EMA 200 (Long Term) Bullish
MACD (12 26 9) MACD Line is Less Then SIGNAL Line Bearish
RSI (14) RSI is 33.69 Sideways
MFI (14) MFI is 44.52 Sideways
CCI (20) CCI is Below -100 Over Sold
WILLIAM %R (14) William %R is -50.73 Sideways
ADX (14) ADX is Above 20 & +DI is Below -DI Down Trend
PSAR Stoploss For Long Buy 113.24
10 Day Avg Volume Traded 11.97 % More then 10 Day Average Volume
 
PANACEABIO Other Details
Segment EQ
Market Capital 13730913280.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
PANACEABIO Address
PANACEABIO
 
PANACEABIO Latest News
 
Your Comments and Response on Panacea Biotec Limited
 
PANACEABIO Business Profile
Panacea Biotec Limited, a biotechnology company, engages in the research and development, manufacture, and marketing of pharmaceuticals, vaccines, and biosimilars in India. It operates through Vaccines and Formulations segments. The company's product portfolio includes prescription products in various therapeutic areas, such as pain management, diabetes and cardiovascular management, oncology, renal disease management, osteoporosis management, anti-tubercular, and gastro-intestinal care; and vaccines for anthrax, dengue, Japanese encephalitis, and others. It also exports its products to over 30 countries worldwide, including the United States, Germany, the Russian Federation, Sri Lanka, the Philippines etc. The company has a collaboration agreement with Russian Direct Investment Fund for producing Covid-19 vaccine, Sputnik-V. Panacea Biotec Limited was incorporated in 1984 and is based in New Delhi, India. Address: B-1 Extension/G-3, New Delhi, India, 110044
 
2005-2021 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service